Arzeda Secures $12,000,000 Series A Funding Round

  • Feed Type
  • Date
    2/27/2009
  • Company Name
    Arzeda
  • Mailing Address
    Undisclosed Seattle, WA 98100
  • Company Description
    ARZEDA has the world-leading computational enzyme design technology and is changing the way people think about biocatalysis. ARZEDA was founded by David Baker and three senior members of his lab to commercialize and further develop its computational enzyme design technology. ARZEDA’s team includes the inventors of the platform and brings more than 20 years of combined experience in the field of computational and experimental protein engineering.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    WRF Capital

By posting a comment, you agree to our terms and conditions.